The MYC oncogene is highly expressed in CTCs from metastatic variants of breast cancer, and it regulates the adaptation of CTCs to the brain environment by reducing the oxidative stress produced by activated microglia via gene upregulation of glutathione peroxidase 1 (GPX1) [46]. The gene discussed is GPX1; the disease is breast carcinoma.